C-Type Lectin-Like Molecule-1 as a Biomarker for Diagnosis and Prognosis in Acute Myeloid Leukemia: A Preliminary Study

OBJECTIVE: AML is a heterogeneous disease both in genomic and proteomic backgrounds, and variable outcomes may appear in the same cytogenetic risk group. Therefore, it is still necessary to identify new antigens that contribute to diagnostic information and to refine the current risk stratification....

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jinghua, Wang, Weida, Chen, Hao, Li, Wenmin, Huang, Tian, Zhang, Weiya, Ling, Wei, Lai, Peilong, Wang, Yulian, Geng, Suxia, Li, Minming, Du, Xin, Weng, Jianyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979301/
https://www.ncbi.nlm.nih.gov/pubmed/33778076
http://dx.doi.org/10.1155/2021/6643948

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979301/
https://www.ncbi.nlm.nih.gov/pubmed/33778076
http://dx.doi.org/10.1155/2021/6643948

Ejemplares similares